24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
66.76% |
|
EBOLA |
18.11% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
10.54% |
|
CANCER |
2.43% |
|
PEPTIDOMIMETIC CD40L BINDING |
2.16% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
62.73% |
|
RCA TEMPERATURE SIMULATIONS |
20.77% |
|
EBOLA |
5.44% |
|
CANCER |
5.03% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
4.04% |
|
PEPTIDOMIMETIC CD40L BINDING |
1.99% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
67.81% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
7.16% |
|
ENZYME DYNAMICS |
6.55% |
|
ATSTP10 SUCROSE TRANSPORT |
4.91% |
|
CANCER |
3.52% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
3.34% |
|
RCA TEMPERATURE SIMULATIONS |
2.71% |
|
EBOLA |
1.01% |
|
ATSTP10 TRANSPORT SIMULATION |
.99% |
|
PEPTIDOMIMETIC CD40L BINDING |
.81% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
.52% |
|
MEMBRANE TRANSPORT |
.25% |
|
RCA OLIGOMER STABILITY SIMULATIONS |
.18% |
|
ATWRI1 MUTANT SCREENING |
.12% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.11% |